Affecting Drugs | |
---|---|
Drug Name | PubMed Articles (year of publication) |
2C-methyl-d-erythritol 2,4-cyclodiphosphate | |
Biochemical characterization, suggested target | |
Crystal structure, suggested target | |
Metabolic control analysis and in silico inhibition studies, ketoclomazone | |
Metabolic network analysis, suggested target | |
N,N'-(4,5-Dibromo-1,2-phenylene)bis(4-bromobenzenesulfonamide) | |
N,N'-(4,5-Dinitro-1,2-phenylene)bis(4-methylbenzenesulfonamide) | |
Suggested target |